Workflows
Six guided analyses for the decisions biopharma teams make most, each run on your own program, brief, or asset in four steps.
A workflow is an analysis Sleuth has already planned for a common job, like choosing a lead indication or deciding whether to license an asset. You describe your case, choose what counts, check the plan, and Sleuth builds the analysis. Every value in it has a source and a confidence score, and the datasets stay in your project to keep working in.
Home suggests workflows based on what you told Sleuth at onboarding, and Workflows in the Studio sidebar opens the full library.
The six workflows
| Workflow | The question it answers | What you get |
|---|---|---|
| Indication selection | Which indication should we lead with? | A recommendation on the lead, the second, and the ones to drop, with the evidence behind every disease |
| Graveyard analysis | Why did drugs like ours fail? | One main cause for each discontinued drug like yours, and whether your design fixes it |
| Standard of care evolution | Who should our first pivotal trial enroll? | The market you'll launch into, redrawn for each readout, and the patient groups ranked |
| Pharma partnering | Which pharma should we pitch? | A ranked list of pharma, with what to lead with and what to bring to each |
| Asset scouting | Which asset should we license first? | A ranked shortlist scored on your criteria, with who holds each asset's rights |
| Asset assessment | Should we license this asset? | A sales forecast built input by input, a score, and a recommendation on terms |
The first three are about your own program. The last three are about other companies and their assets. In Studio, workflows carry their own names (Novel Platform to Positioning, for example). Each page here gives both.
How every workflow runs
- Describe your case. Say what your platform, program, or asset does, the decision you face, and anything you already know. Add a deck or a document if you have one.
- Decide what counts. Choose the criteria that matter, like clinical validation or competitive room, and how much each one counts.
- Shape the plan. Sleuth shows the steps it will run, the outputs, and your credit balance. Add or drop scope, choose Pause at each step or Run end to end, and press Start. Plans and approvals
- Get the analysis. A recommendation with the evidence behind it, the datasets to keep working in, and outputs you can export. Outputs and exports
The plan shows the size of the job before anything runs: rows times analytical columns is the credits it will use, one credit per analytical cell. Questions about results Sleuth already built don't use credits. How credits work
Choosing between them
| If you're deciding | Run |
|---|---|
| Where a new platform or asset should go first | Indication selection |
| Where to take a program next without repeating what ended the drugs before it | Graveyard analysis |
| Which patients a first pivotal trial should enroll | Standard of care evolution |
| Which pharma to approach about your platform, and with what | Pharma partnering |
| Which outside asset to license against a brief | Asset scouting |
| Whether one specific asset is worth licensing, and on what terms | Asset assessment |
| Anything else, like mapping a target, a disease, or a modality | Ask your own question |
Indication selection and graveyard analysis both ask where a platform goes next. Indication selection finds where you'd be first. Graveyard analysis finds where you'd fail the way others did, and many teams run both.
Workflows in Claude, ChatGPT, and Copilot
Workflows run in Studio. From an AI tool, start with the prompt written for the same job: it asks Sleuth for a lighter version of the same analysis in plain words. Prompts to start with
Updated November 9, 2026